Stock 002826 TIBET AIM PHARM. INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Tibet AIM Pharm. Inc.

Equities

002826

CNE100002C39

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
8.91 CNY +0.34% Intraday chart for Tibet AIM Pharm. Inc. +16.93% -24.94%
Apr. 25 Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tibet AIM Pharm. Inc. Proposes Final Cash Dividend for 2023
CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.
CI
Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.
CI
Tibet AIM Pharm. Inc. announces an Equity Buyback for CNY 100 million worth of its shares.
CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tibet AIM Pharm. Inc. authorizes a Buyback Plan.
CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Tibet AIM Pharm. Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 07 July 2023
CI
Tibet AIM Pharm. Inc. Approves Cash Dividend for 2022
CI
Tibet Aim Pharm. Inc. Proposes Final Cash Dividend for the Year 2022
CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Tibet Aim Pharm Chairman Resigns; Successor Named
MT
Tibet Aim Pharm Unit to Buy 21% Stake in US Medtech Firm Pier 88 Health for $6 Million
MT
Tibet AIM Pharm. Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Tibet Aim Pharm. Inc. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares) for the Year 2021, Payable on 8 July 2022
CI
Tibet AIM Pharm. Inc. Approves 2021 Profit Distribution Plan
CI
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002826 Stock
  4. News Tibet AIM Pharm. Inc.